Blood Test Detects Parkinson’s Disease Through Alpha Synuclein Biomarkers
Sunbird Bio demonstrated that its blood-based alpha synuclein biomarkers can accurately detect Parkinson’s disease.
Read MorePosted by Andy Lundin | Nov 8, 2024 | Dementias & Alzheimer’s, Molecular Diagnostics |
Sunbird Bio demonstrated that its blood-based alpha synuclein biomarkers can accurately detect Parkinson’s disease.
Read MorePosted by Andy Lundin | Nov 7, 2024 | Gastrointestinal Infections |
Castle Biosciences’ Barrett’s Esophagus test delivered over 25,000 reports to support risk assessment for Barrett’s Esophagus patients.
Read MorePosted by Andy Lundin | Nov 6, 2024 | Covid 19 |
Nasal autoantibodies can predict COVID severity, providing insights for personalized treatment and applications for other respiratory viruses.
Read MorePosted by Andy Lundin | Nov 4, 2024 | Sequencing Systems, Urinalysis & Toxicology |
Biotia’s BIOTIA-ID Urine NGS Assay uses artificial intelligence (AI) and genomics to deliver rapid, highly accurate UTI diagnoses.
Read MorePosted by Andy Lundin | Nov 4, 2024 | Infectious Diseases |
QIAGEN’s Meningitis/Encephalitis Panel received FDA clearance, providing providers with rapid testing for meningitis and encephalitis.
Read More